⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24906 | 1.00 | — | — | |
| SCHEMBL27292290 | 1.00 | GABRR1 (0.42) | — | |
| SCHEMBL772924 | 1.00 | — | — | |
| SCHEMBL16269701 | 1.00 | GABRR1 (0.42) | — | |
| Hydrochloric Acid SCHEMBL9015216 | 0.97 | — | — | |
| Ammonia Solution, Strong SCHEMBL15129140 | 0.97 | — | — | |
| Methane SCHEMBL28148823 | 0.97 | — | — | |
| Water SCHEMBL28099735 | 0.97 | — | — | |
| Isopropyl Alcohol SCHEMBL1401764 | 0.94 | TSHR (0.44) | — | |
| Alcohol SCHEMBL1401753 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250263376-A1 | (E)-N-CINNAMOYLAMINOALKANOLS WITH MELANOGENESIS INHIBITORY ACTIVITY | UNIWERSYTET JAGIELLONSKI (PL) | 2025-08-21 | — | — | US | claimed |
| CN-118603700-A | Novel universal immunohistochemical antigen retrieval liquid and preparation method thereof | 福州迈新生物技术开发有限公司 | 2024-09-06 | — | — | CN | claimed |
| EP-4324461-A1 | (E)-N-CINAMOYLAMINOALKANOLES WITH MELANOGENESIS INHIBITORY ACTIVITY | UNIWERSYTET JAGIELLONSKI (PL) | 2024-02-21 | — | — | EP | claimed |
| WO-2014073994-A2 | NEW ALKANOLAMIDE DERIVATIVES OF CINNAMIC ACID AND USE OF ALKANOLAMIDE DERIVATIVES OF CINNAMIC ACID FOR PREPARATION OF DRUGS | UNIWERSYTET JAGIELLONSKI (PL) | 2014-05-15 | — | — | WO | claimed |
| US-6287829-B1 | USING CHIRAL ANCHOR-PROTECTIVE GROUPS | DSM FINE CHEMICAL AUSTRIA NFG GMBH & CO KG (AT) | 2001-09-11 | — | — | US | claimed |
| US-20260125383-A1 | INDAZOLE INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF | VENTUS THERAPEUTICS U.S., INC. (US) | 2026-05-07 | — | — | US | disclosed |
| EP-4504883-B1 | FABRIC TREATMENT COMPOSITIONS WITH ANTIOXIDANT MULTIMERS | PROCTER & GAMBLE (US) | 2026-04-29 | — | — | EP | disclosed |
| US-20260108510-A1 | PYRAZOLYL INDAZOLE CGAS INHIBITORS AND USES THEREOF | VENTUS THERAPEUTICS U.S., INC. (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260108509-A1 | 6-MEMBERED HETEROARYL INDAZOLE CGAS INHIBITORS AND USES THEREOF | VENTUS THERAPEUTICS U.S., INC. (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260109704-A1 | 5-MEMBERED HETEROARYL INDAZOLE CGAS INHIBITORS AND USES THEREOF | VENTUS THERAPEUTICS U.S., INC. (US) | 2026-04-23 | — | — | US | disclosed |
| US-12559504-B2 | Benzotriazole derivative | UBE CORPORATION (JP) | 2026-02-24 | — | — | US | disclosed |
| US-12552757-B2 | NRF2-activating compound | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2026-02-17 | — | — | US | disclosed |
| US-20090305998-A1 | HSP90 INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-12-10 | — | — | US | disclosed |
| US-7371733-B2 | Anti bacterial compounds | UTAH STATE UNIVERSITY (US) | 2008-05-13 | — | — | US | disclosed |
| EP-1455777-B1 | GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS | SMITHKLINE BEECHAM PLC (GB) | 2007-11-21 | — | — | EP | disclosed |
| WO-2005049023-A1 | GLYT1 TRANSPORTER INHIBITORS | GLAXO GROUP LIMITED (GB) | 2005-06-02 | — | — | WO | disclosed |
| WO-2003055478-A1 | GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS | SMITHKLINE BEECHAM P.L.C. (GB) | 2003-07-10 | — | — | WO | disclosed |
| US-6287829-B1 | USING CHIRAL ANCHOR-PROTECTIVE GROUPS | DSM FINE CHEMICAL AUSTRIA NFG GMBH & CO KG (AT) | 2001-09-11 | — | — | US | disclosed |
| US-5463046-A | 1-β-methyl-2-thiolic carbapenem derivatives | DONG KOOK PHARMACEUTICAL CO., LTD. (KR) | 1995-10-31 | — | — | US | disclosed |
| EP-0281826-A2 | Process for the preparation of (R)-4-amino-3-hydroxy-butyric acid | Degussa Aktiengesellschaft (DE) | 1988-09-14 | — | — | EP | disclosed |